To provide evidence that LGG‐mediated proresolving and antiangiogenic responses in CRC cells require FPR1, we treated HCT116 shFPR1 and shCTR with LGG SN or with the control broth and we evaluated the production of proresolving and proangiogenic factors. This evidence concerns the gene FPR1 and colorectal carcinoma.